Skip to content
Menu

AIM ImmunoTech Q3 EPS $(0.21) Misses $(0.14) Estimate, Sales $22.000K Down From $26.000K YoY

Benzinga Newsdesk 1 week ago

NewsEarningsEarnings Misses

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.14) by 61.54 percent. This is a 86.62 percent increase over losses of $(1.57) per share from

AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.14) by 61.54 percent. This is a 86.62 percent increase over losses of $(1.57) per share from the same period last year. The company reported $22.000 thousand in sales this quarter. This is a 15.38 percent decrease over sales of $26.000 thousand the same period last year.

Read at benzinga.com